AB007. A resected case of mediastinal myxoid liposarcoma: a case report

AB007. 纵隔黏液样脂肪肉瘤切除病例:病例报告

阅读:1

Abstract

BACKGROUND: Liposarcoma is a malignant soft-tissue tumor that predominantly arises in the extremities and retroperitoneum. Primary mediastinum liposarcoma is extremely rare, accounting for 0.1–0.75% of all mediastinal tumors. Histopathologically, they are classified into four subtypes: well-differentiated, myxoid, pleomorphic, and dedifferentiated types, of which the myxoid type accounts for 30–40%. Here, we report a resected case of myxoid liposarcoma of the anterior mediastinum. CASE DESCRIPTION: A woman in her 50s was referred for an abnormal shadow on a chest X-ray at her medical checkup. Chest computed tomography showed a 40 mm round mass on the left side of the anterior mediastinum, with progressively darker staining and some areas of poor contrast. Magnetic resonance imaging showed T2-weighted high signal in the center with minimal diffusion limitation at the margins. Positron emission tomography showed a 18F-fluorodeoxyglucose avid tumor with maximum uptake value, 2.52. Tumor markers were within normal range. Preoperative diagnosis based on radiological findings was thymoma which was Masaoka I stage. Curative surgical resection was indicated and thoracoscopic total thymectomy was performed. Intraoperative findings showed invasion of the left phrenic nerve, so a combined resection was performed. Pathological examination showed short spindle-shaped atypical cells with dense, unordered proliferation and myxoid matrix deposition in the stroma. Involvement of the left phrenic nerve and diffuse infiltration of the surrounding fatty tissue were also observed. Genomic testing revealed the FUS-DDIT3/CHOP rearrangement. Taken together, the tumor was diagnosed as myxoid liposarcoma. CONCLUSIONS: Myxoid liposarcoma is of intermediate grade and has a relatively good prognosis compared with pleomorphic and dedifferentiated types. However, recurrence mortality rate is reported to be around 60%, and careful postoperative follow-up is necessary.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。